⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2685349 | 1.00 | — | — | |
| SCHEMBL396027 | 1.00 | — | — | |
| Trimethylammonium SCHEMBL9465881 | 0.90 | CA1 (0.35) | — | |
| SCHEMBL196713 | 0.81 | — | — | |
| Methacrylic Acid SCHEMBL4643104 | 0.79 | — | — | |
| SCHEMBL2231916 | 0.79 | SLC22A16 (0.33) | — | |
| SCHEMBL7890405 | 0.78 | — | — | |
| Water SCHEMBL28182528 | 0.73 | — | — | |
| SCHEMBL11795547 | 0.73 | ALDH1A1 (0.33) | — | |
| SCHEMBL7560829 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4499619-A1 | SYNTHESIS OF DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS | The United States of America, as represented by the Secretary, Department of Health and Human Services (US) | 2025-02-05 | — | — | EP | claimed |
| CN-119137108-A | Synthesis of dopamine D3 receptor selective antagonists/partial agonists | 以秘书处、卫生和人类服务部为代表的美利坚合众国 | 2024-12-13 | — | — | CN | claimed |
| CN-115894292-B | Preparation method of L-caprolaconitrile | 山东阳谷华泰化工股份有限公司 | 2024-08-30 | — | — | CN | claimed |
| CN-117843473-A | Preparation method of levocarnitine impurity | 常州寅盛药业有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-116854641-A | Preparation method of 2-piperazine acetonitrile derivative and 2-piperazine acetonitrile | 重庆博腾制药科技股份有限公司 | 2023-10-10 | — | — | CN | claimed |
| WO-2023192145-A1 | SYNTHESIS OF DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-10-05 | — | — | WO | claimed |
| CN-115894292-A | Preparation method of L-Carlactonitrile | 山东阳谷华泰化工股份有限公司 | 2023-04-04 | — | — | CN | claimed |
| CN-115656398-A | Detection method of 4-chloro-3-hydroxybutyronitrile | 北京诺康达医药科技股份有限公司 | 2023-01-31 | — | — | CN | claimed |
| CN-115477594-A | Continuous preparation method of L-canacyanol | 山东阳谷华泰化工股份有限公司 | 2022-12-16 | — | — | CN | claimed |
| CN-113698320-A | Preparation method of L-Carlactonitrile | 抚顺顺能化工有限公司 | 2021-11-26 | — | — | CN | claimed |
| CN-104359990-B | A kind of analyzing detecting method of (S) or (R)-4-chloro-3-hydroxyl butyronitrile | 浙江海正药业股份有限公司 | 2016-09-07 | — | — | CN | claimed |
| CN-104359990-A | Analysis and detection method of (S) or (R)-4-chlorine-3-hydroxyl butyronitrile | ZHEJIANG HISUN PHARM CO LTD | 2015-02-18 | — | — | CN | claimed |
| JP-9323994-A | — | — | None | — | — | JP | disclosed |
| JP-63316758-A | — | — | None | — | — | JP | disclosed |
| US-20260116881-A1 | KIF MODULATOR COMPOUNDS AND METHODS OF USE | IAMBIC THERAPEUTICS INC (US) | 2026-04-30 | — | — | US | disclosed |
| CN-120865019-A | Stereoselective synthesis method of R and S-4-chloro-3-hydroxybutyronitrile | 抚顺顺能化工有限公司 | 2025-10-31 | — | — | CN | disclosed |
| EP-0347818-B1 | Process for preparing 3-pyrrolidinol | KANEGAFUCHI CHEMICAL IND (JP) | 1995-08-23 | — | — | EP | disclosed |
| US-4910320-A | Reducing 4-chloro-3-hydroxybutyronitrile | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1990-03-20 | — | — | US | disclosed |
| EP-0347818-A2 | Process for preparing 3-pyrrolidinol | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1989-12-27 | — | — | EP | disclosed |
| JP-S63316758-A | PRODUCTION OF 4-CHLORO-3-HYDROXYBUTYRONITRILE | OSAKA SODA CO LTD | 1988-12-26 | — | — | JP | disclosed |